Cassinello, Javier <br/><br/>
Multicenter phase II study of fixed sequences of capecitabine combined with oxaliplatin or irinotecan in patients with previously untreated metastatic colorectal cancer.  [electronic resource] 

 -  Clinical colorectal cancer  Mar 2006 
 - 429-35 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study 
<br/><br/><label>ISSN: </label>1533-0028 
<br/><br/><label>Standard No.: </label>10.3816/ccc.2006.n.014  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--drug therapy<br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Camptothecin--administration & dosage<br/>Capecitabine<br/>Colorectal Neoplasms--drug therapy<br/>Deoxycytidine--administration & dosage<br/>Disease-Free Survival<br/>Dose-Response Relationship, Drug<br/>Drug Administration Schedule<br/>Drug-Related Side Effects and Adverse Reactions<br/>Female<br/>Fluorouracil--analogs & derivatives<br/>Humans<br/>Irinotecan<br/>Male<br/>Middle Aged<br/>Organoplatinum Compounds--administration & dosage<br/>Oxaliplatin<br/>Survival Rate